Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Free Cash Flow Generation Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Free Cash Flow Generation Index of 0.86x as of September 2025. Free cash flow of CN¥131.73 Million represents 1% of operating cash flow (CN¥153.30 Million). Explore Tianjin Chase Sun Pharmaceutical Co Ltd (300026) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Chase Sun Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Tianjin Chase Sun Pharmaceutical Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Tianjin Chase Sun Pharmaceutical Co Ltd. Check total reinvestment intensity of Tianjin Chase Sun Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.77x | CN¥659.12 Million | CN¥852.24 Million | CN¥193.12 Million | ▲ +0.0% |
| 2023 | 0.77x | CN¥1.18 Billion | CN¥1.53 Billion | CN¥347.12 Million | ▲ +2411.9% |
| 2022 | -0.03x | CN¥-24.93 Million | CN¥745.35 Million | CN¥770.27 Million | ▲ +95.4% |
| 2021 | -0.73x | CN¥-285.85 Million | CN¥391.60 Million | CN¥677.45 Million | ▲ +60.9% |
| 2020 | -1.87x | CN¥-367.12 Million | CN¥196.66 Million | CN¥563.78 Million | ▼ -7.6% |
| 2019 | -1.73x | CN¥-374.91 Million | CN¥216.10 Million | CN¥591.01 Million | ▼ -821.8% |
| 2018 | 0.24x | CN¥93.30 Million | CN¥388.19 Million | CN¥294.89 Million | ▼ -50.3% |
| 2017 | 0.48x | CN¥359.04 Million | CN¥742.38 Million | CN¥383.34 Million | ▲ +565.7% |
| 2016 | 0.07x | CN¥32.55 Million | CN¥448.08 Million | CN¥415.52 Million | ▲ +108.6% |
| 2015 | -0.85x | CN¥-102.36 Million | CN¥121.00 Million | CN¥223.35 Million | ▼ -346.1% |
| 2014 | -0.19x | CN¥-28.43 Million | CN¥149.94 Million | CN¥178.37 Million | ▼ -174.8% |
| 2013 | 0.25x | CN¥36.40 Million | CN¥143.60 Million | CN¥107.20 Million | ▲ +156.0% |
| 2012 | -0.45x | CN¥-68.95 Million | CN¥152.21 Million | CN¥221.17 Million | ▲ +92.9% |
| 2011 | -6.37x | CN¥-226.87 Million | CN¥35.64 Million | CN¥262.51 Million | ▼ -341.7% |
| 2010 | -1.44x | CN¥-66.65 Million | CN¥46.25 Million | CN¥112.90 Million | ▼ -328.4% |
| 2009 | 0.63x | CN¥85.24 Million | CN¥135.06 Million | CN¥49.82 Million | ▲ +66.5% |
| 2008 | 0.38x | CN¥29.46 Million | CN¥77.74 Million | CN¥48.28 Million | ▼ -58.7% |
| 2007 | 0.92x | CN¥66.14 Million | CN¥72.01 Million | CN¥5.87 Million | ▲ +159.4% |
| 2006 | -1.54x | CN¥-1.89 Million | CN¥1.22 Million | CN¥3.12 Million | — |